{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:43:48Z","timestamp":1764603828515},"reference-count":28,"publisher":"Medical Association of Nippon Medical School","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2022,12,25]]},"DOI":"10.1272\/jnms.jnms.2022_89-605","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T22:12:21Z","timestamp":1637878341000},"page":"616-622","source":"Crossref","is-referenced-by-count":1,"title":["Cytological Assessment of Desmoplastic Malignant Pleural Mesothelioma in an Autopsy Case"],"prefix":"10.1272","volume":"89","author":[{"given":"Yoko","family":"Kawamoto","sequence":"first","affiliation":[{"name":"Department of Integrated Diagnostic Pathology, Graduate School of Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Kure","sequence":"additional","affiliation":[{"name":"Department of Integrated Diagnostic Pathology, Graduate School of Medicine, Nippon Medical School"},{"name":"Department of Diagnostic Pathology, Nippon Medical School Musashikosugi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Katayama","sequence":"additional","affiliation":[{"name":"Department of Medical Technology and Sciences, International University of Health and Welfare"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoko","family":"Kawahara","sequence":"additional","affiliation":[{"name":"Department of Integrated Diagnostic Pathology, Graduate School of Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Teduka","sequence":"additional","affiliation":[{"name":"Department of Integrated Diagnostic Pathology, Graduate School of Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Kunugi","sequence":"additional","affiliation":[{"name":"Department of Analytic Human Pathology, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munehiko","family":"Onda","sequence":"additional","affiliation":[{"name":"Department of Integrated Diagnostic Pathology, Graduate School of Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Motoda","sequence":"additional","affiliation":[{"name":"Department of Integrated Diagnostic Pathology, Graduate School of Medicine, Nippon Medical School"},{"name":"Department of Diagnostic Pathology, Nippon Medical School Musashikosugi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuji","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Department of Integrated Diagnostic Pathology, Graduate School of Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hashimoto K, Okuma Y, Hosomi Y, Hishima T. Malignant mesothelioma of the pleura with desmoplastic histology: a case series and literature review. BMC Cancer [Internet]. 2016 Sep 6;16:718. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27599565","DOI":"10.1186\/s12885-016-2745-8"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kushitani K, Takeshima Y, Amatya VJ, Furonaka O, Sakatani A, Inai K. Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry. Pathol Int [Internet]. 2008 Feb;58 (2):75-83. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18199156","DOI":"10.1111\/j.1440-1827.2007.02193.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tsuji S, Washimi K, Kageyama T, et al. HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma. Sci Rep [Internet]. 2017 Mar 31;7:45768. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28361969","DOI":"10.1038\/srep45768"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Husain AN, Mirza MK, Gibbs A, et al. How useful is GLUT-1 in differentiating mesothelial hyperplasia and fibrosing pleuritis from epithelioid and sarcomatoid mesotheliomas? An international collaborative study. Lung Cancer [Internet]. 2014 Mar;83 (3):324-8. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24440278","DOI":"10.1016\/j.lungcan.2013.12.009"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Minato H, Kurose N, Fukushima M, et al. Comparative immunohistochemical analysis of IMP3, GLUT1, EMA, CD146, and desmin for distinguishing malignant mesothelioma from reactive mesothelial cells. Am J Clin Pathol [Internet]. 2014 Jan;141 (1):85-93. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24343741","DOI":"10.1309\/AJCP5KNL7QTELLYI"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Carbone M, Shimizu D, Napolitano A, et al. Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma. Oncotarget [Internet]. 2016 Sep 13;7 (37):59314-21. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27447750","DOI":"10.18632\/oncotarget.10653"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Amatya VJ, Kushitani K, Mawas AS, et al. MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma. Mod Pathol [Internet]. 2017 May;30 (5):672-81. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28128276","DOI":"10.1038\/modpathol.2016.181"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Venkatachala S, Shivakumar S, Prabhu M, Padilu R. Histomorphological and Immunohistochemical Analysis of Pleural Neoplasms. Iran J Pathol [Internet]. 2018 Spring;13 (2):196-204. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30697290","DOI":"10.30699\/ijp.13.2.196"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tandon RT, Jimenez-Cortez Y, Taub R, Borczuk AC. Immunohistochemistry in peritoneal mesothelioma: A single-center experience of 244 cases. Arch Pathol Lab Med [Internet]. 2018 Feb;142 (2):236-42. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29048219","DOI":"10.5858\/arpa.2017-0092-OA"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Mawas AS, Amatya VJ, Kushitani K, et al. MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung. Sci Rep [Internet]. 2018 Jan 9;8 (1):134. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29317712","DOI":"10.1038\/s41598-017-18545-x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Truong LD, Maccato ML, Awalt H, Cagle PT, Schwartz MR, Kaplan AL. Serous surface carcinoma of the peritoneum: a clinicopathologic study of 22 cases. Hum Pathol [Internet]. 1990 Jan;21 (1):99-110. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1688545","DOI":"10.1016\/0046-8177(90)90081-F"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Comin CE, Dini S, Novelli L, Santi R, Asirelli G, Messerini L. h-Caldesmon, a useful positive marker in the diagnosis of pleural malignant mesothelioma, epithelioid type. Am J Surg Pathol [Internet]. 2006 Apr;30 (4):463-9. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16625092","DOI":"10.1097\/00000478-200604000-00006"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Khalidi HS, Medeiros LJ, Battifora H. Lymphohistiocytoid mesothelioma. An often misdiagnosed variant of sarcomatoid malignant mesothelioma. Am J Clin Pathol [Internet]. 2000 May;113 (5):649-54. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10800396","DOI":"10.1309\/7ECY-KN61-PP1M-52EB"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kinoshita Y, Takasu K, Yuri T, et al. Two cases of malignant peritoneal mesothelioma without asbestos exposure: cytologic and immunohistochemical features. Ann Diagn Pathol [Internet]. 2013 Feb;17 (1):99-103. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22784439","DOI":"10.1016\/j.anndiagpath.2012.05.007"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hasteh F, Lin GY, Weidner N, Michael CW. The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions. Cancer Cytopathol [Internet]. 2010 Apr 25;118 (2):90-6. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20209622","DOI":"10.1002\/cncy.20071"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Chapel DB, Churg A, Santoni-Rugiu E, Tsujimura T, Hiroshima K, Husain AN. Molecular pathways and diagnosis in malignant mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group. Lung Cancer [Internet]. 2019 Jan;127:69-75. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30642555","DOI":"10.1016\/j.lungcan.2018.11.032"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Bishop JA, Sharma R, Illei PB. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. Hum Pathol [Internet]. 2010 Jan;41 (1):20-5. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19740516","DOI":"10.1016\/j.humpath.2009.06.014"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Gumurdulu D, Zeren EH, Cagle PT, et al. Specificity of MOC-31 and HBME-1 immunohistochemistry in the differential diagnosis of adenocarcinoma and malignant mesothelioma: a study on environmental malignant mesothelioma cases from Turkish villages. Pathol Oncol Res [Internet]. 2002;8 (3):188-93. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12515999","DOI":"10.1007\/BF03032393"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Pettersson T, Froseth B, Riska H, Klockars M. Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma. Chest [Internet]. 1988 Nov;94 (5):1037-9. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3180855","DOI":"10.1378\/chest.94.5.1037"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Fujimoto N, Gemba K, Asano M, et al. Hyaluronic acid in the pleural fluid of patients with malignant pleural mesothelioma. Respir Investig [Internet]. 2013 Jun;51 (2):92-7. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23790737","DOI":"10.1016\/j.resinv.2013.02.002"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Creaney J, Dick IM, Segal A, Musk AW, Robinson BW. Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma. Lung Cancer [Internet]. 2013 Dec;82 (3):491-8. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24161718","DOI":"10.1016\/j.lungcan.2013.09.016"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Matsumoto S, Nabeshima K, Kamei T, et al. Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology. Cancer Cytopathol [Internet]. 2013 Aug;121 (8):415-22. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23450849","DOI":"10.1002\/cncy.21269"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ko HM, Kamil ZS, Geddie WR. Microcystic variant malignant mesothelioma presenting as a localized paraspinal mass. CytoJournal. 2014;11:16.","DOI":"10.4103\/1742-6413.134438"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kawai T, Kawashima K, Serizawa H, Miura H, Kyeongil K. Adenomatoid mesothelioma with intranuclear inclusion bodies: a case report with cytological and histological findings. Diagn Cytopathol [Internet]. 2014 May;42 (5):436-40. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23166110","DOI":"10.1002\/dc.22932"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Wu D, Hiroshima K, Matsumoto S, et al. Diagnostic usefulness of p16\/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis. Am J Clin Pathol [Internet]. 2013 Jan;139 (1):39-46. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23270897\/","DOI":"10.1309\/AJCPT94JVWIHBKRD"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Hida T, Matsumoto S, Hamasaki M, et al. Deletion status of p16 in effusion smear preparation correlates with that of underlying malignant pleural mesothelioma tissue. Cancer science. 2015 Nov;106 (11):1635-41.","DOI":"10.1111\/cas.12769"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Tochigi N, Attanoos R, Chirieac LR, Allen TC, Cagle PT, Dacic S. p16 deletion in sarcomatoid tumors of the lung and pleura. Arch Pathol Lab Med [Internet]. 2013 May;137 (5):632-6. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23627453\/","DOI":"10.5858\/arpa.2012-0108-OA"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Illei PB, Ladanyi M, Rusch VW, Zakowski MF. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions. Cancer. 2003 Feb 25;99 (1):51-6.","DOI":"10.1002\/cncr.10923"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/89\/6\/89_JNMS.2022_89-605\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:56:59Z","timestamp":1715317019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/89\/6\/89_JNMS.2022_89-605\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,25]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.jnms.2022_89-605","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,25]]},"article-number":"JNMS.2022_89-605"}}